| Autor: |
Parlow, J. J., Kurumbail, R. G., Stegeman, R. A., Stevens, A. M., Stallings, W. C., South, M. S. |
| Zdroj: |
Journal of Medicinal Chemistry; October 2003, Vol. 46 Issue: 22 p4696-4701, 6p |
| Abstrakt: |
Targeted 2-pyridones were selected as tissue Factor VIIa inhibitors and prepared from 2,6-dibromopyridine via a multistep synthesis. A variety of chemical transformations, including regioselective nucleophilic addition, selective nitrogen alkylation, and a Suzuki coupling, afforded the targeted tissue Factor VIIa inhibitors. The pyridone core was selected as a replacement for the pyrazinone core of noncovalent tissue Factor VIIa inhibitors and designed such that their substitution pattern would occupy and interact with the S1, S2, and S3 pockets of the tissue Factor VIIa enzyme. These compounds were tested in several serine protease enzyme assays involved in the coagulation cascade exhibiting modest activity on tissue Factor VIIa with excellent selectivity over thrombin and Factor Xa. Finally, an X-ray crystal structure of inhibitor 14a bound to tissue Factor VIIa was obtained and will be described. |
| Databáze: |
Supplemental Index |
| Externí odkaz: |
|
